Article

Supplement to enhance blepharospasm therapy now available by prescription only

A medical food (Zytaze, OCuSOFT) designed to provide nutritional support to enhance the effectiveness of injections of onabotulinum toxin A (Botox/Botox Cosmetic, Allergan), abobotulinum toxin A (Dysport, Tercica), and rimabotulinum toxin B (Myobloc, Solstice Neurosciences) in the treatment of blepharospasm, hemifacial spasm, and cosmetic procedures now is available in pharmacies as a prescription-only supplement.

Richmond, TX-A medical food (Zytaze, OCuSOFT) designed to provide nutritional support to enhance the effectiveness of injections of onabotulinum toxin A (Botox/Botox Cosmetic, Allergan), abobotulinum toxin A (Dysport, Tercica), and rimabotulinum toxin B (Myobloc, Solstice Neurosciences) in the treatment of blepharospasm, hemifacial spasm, and cosmetic procedures now is available in pharmacies as a prescription-only supplement. 

Formulated with a proprietary, patent-pending blend of highly bioavailable organic zinc and phytase, the product also has been reported to extend the duration of the injection treatments by almost 25%. It is taken 4 days before and on the day of a planned injection (two capsules per day). 

In the event that the supplement is not available at a local pharmacy, eye-care professionals can inform the pharmacy that it can be ordered directly from a wholesale distributor. The company anticipates increased availability through additional wholesale distributors and pharmacies soon.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
© 2025 MJH Life Sciences

All rights reserved.